Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Equity Ratio (2020 - 2025)

Historic Equity Ratio for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to 0.59.

  • GeneDx Holdings' Equity Ratio rose 1829.97% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year increase of 1829.97%. This contributed to the annual value of 0.58 for FY2024, which is 739.64% up from last year.
  • As of Q3 2025, GeneDx Holdings' Equity Ratio stood at 0.59, which was up 1829.97% from 0.6 recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Equity Ratio registered a high of 0.7 during Q4 2021, and its lowest value of 3.23 during Q2 2021.
  • In the last 5 years, GeneDx Holdings' Equity Ratio had a median value of 0.59 in 2025 and averaged 0.24.
  • As far as peak fluctuations go, GeneDx Holdings' Equity Ratio skyrocketed by 565773.58% in 2021, and later tumbled by 2622.07% in 2022.
  • Over the past 5 years, GeneDx Holdings' Equity Ratio (Quarter) stood at 0.7 in 2021, then dropped by 26.22% to 0.52 in 2022, then grew by 5.37% to 0.54 in 2023, then increased by 7.4% to 0.58 in 2024, then grew by 1.19% to 0.59 in 2025.
  • Its Equity Ratio stands at 0.59 for Q3 2025, versus 0.6 for Q2 2025 and 0.58 for Q1 2025.